Regulation
FDA approves Cordis SELUTION SLR for coronary in-stent restenosis
The US FDA has approved Cordis' SELUTION SLR (sustained limus release) drug-eluting balloon for treatment of coronary in-stent restenosis. The approval expands the indication for the device beyond its previous clearance.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network